Intuitive Surgical Inc header image

Intuitive Surgical Inc

ISRG

Equity

ISIN US46120E6023 / Valor 1631646

NASDAQ (2024-11-21)
USD 550.62+1.62%

Intuitive Surgical Inc
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Intuitive Surgical Inc is a global leader in the field of minimally invasive surgical solutions, with a focus on developing innovative robotic-assisted surgical systems and data generation services. With nearly three decades of experience, the company has revolutionized the way surgeries are performed, providing healthcare professionals with advanced tools to improve patient outcomes. Intuitive Surgical Inc's cutting-edge technology has the potential to transform healthcare systems around the world, making surgical procedures more precise, efficient, and effective.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Revenue Growth

Intuitive Surgical Inc. reported a revenue of $2.01 billion for the second quarter of 2024, marking a 14% increase compared to $1.76 billion in the second quarter of 2023. This growth was primarily driven by an increase in da Vinci procedure volume and a larger installed base of systems.

System Placements

During the second quarter of 2024, Intuitive Surgical Inc. placed 341 da Vinci surgical systems, including 70 da Vinci 5 systems. This is a slight increase from the 331 systems placed in the second quarter of 2023. The total installed base of da Vinci systems grew to 9,203, a 14% increase from the previous year.

Net Income

Intuitive Surgical Inc. reported a GAAP net income of $527 million, or $1.46 per diluted share, for the second quarter of 2024. This represents an increase from the $421 million, or $1.18 per diluted share, reported in the second quarter of 2023. On a non-GAAP basis, net income was $641 million, or $1.78 per diluted share, compared to $507 million, or $1.42 per diluted share, in the same period last year.

Instruments and Accessories Revenue

Revenue from instruments and accessories for Intuitive Surgical Inc. increased by 16% to $1.24 billion in the second quarter of 2024, compared to $1.08 billion in the second quarter of 2023. This growth was driven by a 17% increase in da Vinci procedure volume and an 82% increase in Ion procedure volume.

Cash and Investments

As of the end of the second quarter of 2024, Intuitive Surgical Inc. had $7.68 billion in cash, cash equivalents, and investments. This represents an increase of $360 million during the quarter, primarily driven by cash generated from operations, partially offset by capital expenditures.

Summarized from source with an LLMView Source

Key figures

76.6%1Y
57.9%3Y
189%5Y

Performance

26.7%1Y
34.5%3Y
35.5%5Y

Volatility

Market cap

192985 M

Market cap (USD)

Daily traded volume (Shares)

514,899

Daily traded volume (Shares)

1 day high/low

551.78 / 540.89

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.50
Robin Roten
Switzerland, 19 Oct 2022
star star star star star
Tej Ram Kumpakha
Switzerland, 12 Apr 2022
star star star star star
attractive revenue growth

EQUITIES OF THE SAME SECTOR

PeptiDream KK
PeptiDream KK PeptiDream KK Valor: 21362320
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%JPY 2,563.50
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%EUR 18.28
PharmaSGP Holding SE
PharmaSGP Holding SE PharmaSGP Holding SE Valor: 55294050
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%EUR 23.60
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.89%DKK 873.20
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%DKK 258.00
KK AIN HOLDINGS
KK AIN HOLDINGS KK AIN HOLDINGS Valor: 961399
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.32%JPY 4,937.00
Astellas Seiyaku KK
Astellas Seiyaku KK Astellas Seiyaku KK Valor: 764030
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%JPY 1,572.00
KK Menicon
KK Menicon KK Menicon Valor: 28349340
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.05%JPY 1,555.00
KK Tsumura
KK Tsumura KK Tsumura Valor: 763996
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.31%JPY 4,823.00
Mani KK
Mani KK Mani KK Valor: 1241365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.59%JPY 1,754.50